Despite the significance of redox post-translational modifications (PTMs) in regulating diverse signal transduction pathways, the enzymatic systems that catalyze reversible and specific oxidative or reductive modifications have yet to be firmly established. Thioredoxin 1 (Trx1) is a conserved antioxidant protein that is well known for its disulfide reductase activity. Interestingly, Trx1 is also able to transnitrosylate or denitrosylate (defined as processes to transfer or remove a nitric oxide entity to/from substrates) specific proteins. An intricate redox regulatory mechanism has recently been uncovered that accounts for the ability of Trx1 to catalyze these different redox PTMs. In this review, we will summarize the available evidence in support of Trx1 as a specific disulfide reductase, and denitrosylation and transnitrosylation agent, as well as the biological significance of the diverse array of Trx1-regulated pathways and processes under different physiological contexts. The dramatic progress in redox proteomics techniques has enabled the identification of an increasing number of proteins, including peroxiredoxin 1, whose disulfide bond formation and nitrosylation status are regulated by Trx1. This review will also summarize the advancements of redox proteomics techniques for the identification of the protein targets of Trx1-mediated PTMs. Collectively, these studies have shed light on the mechanisms that regulate Trx1-mediated reduction, transnitrosylation, and denitrosylation of specific target proteins, solidifying the role of Trx1 as a master regulator of redox signal transduction. Antioxid. Redox Signal. 15, 2565–2604.
AbbasK, BretonJ, DrapierJC. The interplay between nitric oxide and peroxiredoxins. Immunobiology, 213:815–822. 2008.
2.
AdachiT, PimentelDR, HeibeckT, HouX, LeeYJ, JiangB, IdoY, CohenRA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem, 279:29857–29862. 2004.
3.
AgoT, LiuT, ZhaiP, ChenW, LiH, MolkentinJD, VatnerSF, SadoshimaJ. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell, 133:978–993. 2008.
4.
AgoT, SadoshimaJ. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal, 9:679–687. 2007.
5.
AkamatsuY, OhnoT, HirotaK, KagoshimaH, YodoiJ, ShigesadaK. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J Biol Chem, 272:14497–14500. 1997.
6.
AracenaP, TangW, HamiltonSL, HidalgoC. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal, 7:870–881. 2005.
7.
ArnerES, HolmgrenA. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 267:6102–6109. 2000.
8.
ArnerES, HolmgrenA. The thioredoxin system in cancer. Semin Cancer Biol, 16:420–426. 2006.
9.
ArnoldWP, MittalCK, KatsukiS, MuradF. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A, 74:3203–3207. 1977.
10.
AslundF, BerndtKD, HolmgrenA. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J Biol Chem, 272:30780–30786. 1997.
11.
Atochina-VassermanEN, GowAJ, AbramovaH, GuoCJ, TomerY, PrestonAM, BeckJM, BeersMF. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J Immunol, 182:2277–2287. 2009.
12.
AvvalFZ, HolmgrenA. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalians phase ribonucleotide reductase. J Biol Chem, 284:8233–8240. 2009.
13.
BacksJ, OlsonEN. Control of cardiac growth by histone acetylation/deacetylation. Circ Res, 98:15–24. 2006.
14.
BakerA, PayneCM, BriehlMM, PowisG. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res, 57:5162–5167. 1997.
15.
BalmerY, KollerA, del ValG, ManieriW, SchurmannP, BuchananBB. Proteomics gives insight into the regulatory function of chloroplast thioredoxins. Proc Natl Acad Sci U S A, 100:370–375. 2003.
16.
BalmerY, VenselWH, TanakaCK, HurkmanWJ, GelhayeE, RouhierN, JacquotJP, ManieriW, SchurmannP, DrouxM, BuchananBB. Thioredoxin links redox to the regulation of fundamental processes of plant mitochondria. Proc Natl Acad Sci U S A, 101:2642–2647. 2004.
17.
BaroneE, TrombinoS, CassanoR, SgambatoA, De PaolaB, Di StasioE, PicciN, PreziosiP, MancusoC. Characterization of the S-denitrosylating activity of bilirubin. J Cell Mol Med, 13:2365–2375. 2009.
18.
BasuS, GrubinaR, HuangJ, ConradieJ, HuangZ, JeffersA, JiangA, HeX, AzarovI, SeibertR, MehtaA, PatelR, KingSB, HoggN, GhoshA, GladwinMT, Kim-ShapiroDB. Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol, 3:785–794. 2007.
19.
BatyJW, HamptonMB, WinterbournCC. Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics, 2:1261–1266. 2002.
20.
BeckmanJS, KoppenolWH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 271:C1424–C1437. 1996.
21.
BenharM, ForresterMT, HessDT, StamlerJS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science, 320:1050–1054. 2008.
22.
BenharM, ForresterMT, StamlerJS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol, 10:721–732. 2009.
23.
BenharM, ThompsonJW, MoseleyMA, StamlerJS. Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. Biochemistry, 49:6963–6969. 2010.
24.
BennettCF, BalcarekJM, VarrichioA, CrookeST. Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature, 334:268–270. 1988.
25.
BentzBG, SimmonsRL, HainesGK3rd, RadosevichJA. The yin and yang of nitric oxide: reflections on the physiology and pathophysiology of NO. Head Neck, 22:71–83. 2000.
26.
BertiniR, HowardOM, DongHF, OppenheimJJ, BizzarriC, SergiR, CaselliG, PaglieiS, RominesB, WilshireJA, MengozziM, NakamuraH, YodoiJ, PekkariK, GurunathR, HolmgrenA, HerzenbergLA, HerzenbergLA, GhezziP. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med, 189:1783–1789. 1999.
27.
BloomfieldKL, OsborneSA, KennedyDD, ClarkeFM, TonissenKF. Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene, 319:107–116. 2003.
28.
BogumilR, NamgaladzeD, SchaarschmidtD, SchmachtelT, HellsternS, MutzelR, UllrichV. Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur J Biochem, 267:1407–1415. 2000.
29.
BrennanJP, WaitR, BegumS, BellJR, DunnMJ, EatonP. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem, 279:41352–41360. 2004.
30.
BroilletMC, FiresteinS. Beta subunits of the olfactory cyclic nucleotide-gated channel form a nitric oxide activated Ca2+channel. Neuron, 18:951–958. 1997.
31.
BruickRK, McKnightSL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294:1337–1340. 2001.
32.
CalabreseV, CorneliusC, RizzarelliE, OwenJB, Dinkova-KostovaAT, ButterfieldDA. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal, 11:2717–2739. 2009.
33.
CalabreseV, MancusoC, CalvaniM, RizzarelliE, ButterfieldDA, StellaAM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci, 8:766–775. 2007.
34.
CameriniS, PolciML, RestucciaU, UsuelliV, MalgaroliA, BachiA. A novel approach to identify proteins modified by nitric oxide: the HIS-TAG switch method. J Proteome Res, 6:3224–3231. 2007.
35.
CarvalhoAP, FernandesPA, RamosMJ. Similarities and differences in the thioredoxin superfamily. Prog Biophys Mol Biol, 91:229–248. 2006.
36.
CarvalhoAT, FernandesPA, SwartM, Van StralenJN, BickelhauptFM, RamosMJ. Role of the variable active site residues in the function of thioredoxin family oxidoreductases. J Comput Chem, 30:710–724. 2009.
37.
CasagrandeS, BonettoV, FratelliM, GianazzaE, EberiniI, MassignanT, SalmonaM, ChangG, HolmgrenA, GhezziP. Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci U S A, 99:9745–9749. 2002.
38.
ChaMK, KimIH. Disulfide between Cys392 and Cys438 of human serum albumin is redox-active, which is responsible for the thioredoxin-supported lipid peroxidase activity. Arch Biochem Biophys, 445:19–25. 2006.
39.
ChaeHZ, KimHJ, KangSW, RheeSG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract, 45:101–112. 1999.
40.
ChaiYC, JungCH, LiiCK, AshrafSS, HendrichS, WolfB, SiesH, ThomasJA. Identification of an abundant S-thiolated rat liver protein as carbonic anhydrase III; characterization of S-thiolation and dethiolation reactions. Arch Biochem Biophys, 284:270–278. 1991.
41.
ChenCY, WillardD, RudolphJ. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. Biochemistry, 48:1399–1409. 2009.
42.
ChenYJ, KuWC, LinPY, ChouHC, KhooKH. S-alkylating labeling strategy for site-specific identification of the s-nitrosoproteome. J Proteome Res, 9:6417–6439. 2010.
ChevionM, BerenshteinE, StadtmanER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res, 33,Suppl:S99–S108. 2000.
45.
ChiuehCC, RauhalaP. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic Res, 31:641–650. 1999.
46.
ChoiHI, LeeSP, KimKS, HwangCY, LeeYR, ChaeSK, KimYS, ChaeHZ, KwonKS. Redox-regulated cochaperone activity of the human DnaJ homolog Hdj2. Free Radic Biol Med, 40:651–659. 2006.
47.
ChoiYB, TennetiL, LeDA, OrtizJ, BaiG, ChenHS, LiptonSA. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci, 3:15–21. 2000.
48.
ChouchaniET, HurdTR, NadtochiySM, BrookesPS, FearnleyIM, LilleyKS, SmithRA, MurphyMP. Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J, 430:49–59. 2010.
49.
ChuK, VojtchovskyJ, McMahonBH, SweetRM, BerendzenJ, SchlichtingI. Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin. Nature, 403:921–923. 2000.
50.
CummingRC, AndonNL, HaynesPA, ParkM, FischerWH, SchubertD. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem, 279:21749–21758. 2004.
51.
D'AutreauxB, ToledanoMB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol, 8:813–824. 2007.
52.
DeMorrowS, FrancisH, GaudioE, UenoY, VenterJ, OnoriP, FranchittoA, VaculinB, VaculinS, AlpiniG. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol, 294:G506–G519. 2008.
53.
de PinaMZ, Vazquez-MezaH, PardoJP, RendonJL, Villalobos-MolinaR, Riveros-RosasH, PinaE. Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin. J Biol Chem, 283:12373–12386. 2008.
54.
DerakhshanB, HaoG, GrossSS. Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc Res, 75:210–219. 2007.
55.
DietA, AbbasK, BoutonC, GuillonB, TomaselloF, FourquetS, ToledanoMB, DrapierJC. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem, 282:36199–36205. 2007.
56.
DunnLL, BuckleAM, CookeJP, NgMK. The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol, 30:2089–2098. 2010.
57.
EkmekciogluS, EllerhorstJ, SmidCM, PrietoVG, MunsellM, BuzaidAC, GrimmEA. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res, 6:4768–4775. 2000.
58.
EmaM, HirotaK, MimuraJ, AbeH, YodoiJ, SogawaK, PoellingerL, Fujii-KuriyamaY. Molecular mechanisms of transcription activation by HLF and HIF1 alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J, 18:1905–1914. 1999.
59.
EpsteinAC, GleadleJM, McNeillLA, HewitsonKS, O'RourkeJ, MoleDR, MukherjiM, MetzenE, WilsonMI, DhandaA, TianYM, MassonN, HamiltonDL, JaakkolaP, BarsteadR, HodgkinJ, MaxwellPH, PughCW, SchofieldCJ, RatcliffePJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107:43–54. 2001.
60.
ErwinPA, LinAJ, GolanDE, MichelT. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem, 280:19888–19894. 2005.
61.
ErwinPA, MitchellDA, SartorettoJ, MarlettaMA, MichelT. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem, 281:151–157. 2006.
62.
EssexDW, LiM, MillerA, FeinmanRD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry, 40:6070–6075. 2001.
63.
EuJP, SunJ, XuL, StamlerJS, MeissnerG. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell, 102:499–509. 2000.
64.
FangJ, HolmgrenA. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc, 128:1879–1885. 2006.
65.
FangJ, NakamuraT, ChoDH, GuZ, LiptonSA. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104:18742–18747. 2007.
66.
FangM, JaffreySR, SawaA, YeK, LuoX, SnyderSH. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron, 28:183–193. 2000.
67.
FoglioMH, DuesterG. Characterization of the functional gene encoding mouse class III alcohol dehydrogenase (glutathione-dependent formaldehyde dehydrogenase) and an unexpressed processed pseudogene with an intact open reading frame. Eur J Biochem, 237:496–504. 1996.
68.
FoloppeN, NilssonL. The glutaredoxin -C-P-Y-C- motif: influence of peripheral residues. Structure, 12:289–300. 2004.
69.
FoloppeN, SagemarkJ, NordstrandK, BerndtKD, NilssonL. Structure, dynamics and electrostatics of the active site of glutaredoxin 3 from Escherichia coli: comparison with functionally related proteins. J Mol Biol, 310:449–470. 2001.
70.
FomenkoDE, GladyshevVN. Identity and functions of CxxC-derived motifs. Biochemistry, 42:11214–11225. 2003.
71.
ForresterMT, SethD, HausladenA, EylerCE, FosterMW, MatsumotoA, BenharM, MarshallHE, StamlerJS. Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation. J Biol Chem, 284:36160–36166. 2009.
72.
ForresterMT, ThompsonJW, FosterMW, NogueiraL, MoseleyMA, StamlerJS. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol, 27:557–559. 2009.
73.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15:391–404. 2009.
74.
FuC, HuJ, LiuT, AgoT, SadoshimaJ, LiH. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res, 7:3789–3802. 2008.
75.
FuC, WuC, LiuT, AgoT, ZhaiP, SadoshimaJ, LiH. Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics, 8:1674–1687. 2009.
76.
FujiiJ, IkedaY. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep, 7:123–130. 2002.
77.
GallegosA, GasdaskaJR, TaylorCW, Paine-MurrietaGD, GoodmanD, GasdaskaPY, BerggrenM, BriehlMM, PowisG. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res, 56:5765–5770. 1996.
78.
GalloglyMM, MieyalJJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol, 7:381–391. 2007.
79.
GalloglyMM, StarkeDW, MieyalJJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal, 11:1059–1081. 2009.
80.
GasdaskaJR, KirkpatrickDL, MontfortW, KuperusM, HillSR, BerggrenM, PowisG. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73—>Ser mutation. Biochem Pharmacol, 52:1741–1747. 1996.
GoYM, HalveyPJ, HansenJM, ReedM, PohlJ, JonesDP. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol, 171:1670–1681. 2007.
83.
GodoyL, Gonzalez-DuarteR, AlbalatR. S-nitrosogluthathione reductase activity of amphioxus ADH3: insights into the nitric oxide metabolism. Int J Biol Sci, 2:117–124. 2006.
84.
GormanJJ, WallisTP, PittJJ. Protein disulfide bond determination by mass spectrometry. Mass Spectrom Rev, 21:183–216. 2002.
85.
GrecoTM, HodaraR, ParastatidisI, HeijnenHF, DennehyMK, LieblerDC, IschiropoulosH. Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci U S A, 103:7420–7425. 2006.
86.
GuoY, EinhornL, KelleyM, HirotaK, YodoiJ, ReinboldR, ScholerH, RamseyH, HromasR. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin. Stem Cells, 22:259–264. 2004.
87.
GygiSP, RistB, GerberSA, TurecekF, GelbMH, AebersoldR. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol, 17:994–999. 1999.
88.
HaendelerJ, HoffmannJ, TischlerV, BerkBC, ZeiherAM, DimmelerS. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol, 4:743–749. 2002.
89.
HaendelerJ, HoffmannJ, ZeiherAM, DimmelerS. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation, 110:856–861. 2004.
90.
HagglundP, BunkenborgJ, MaedaK, SvenssonB. Identification of thioredoxin disulfide targets using a quantitative proteomics approach based on isotope-coded affinity tags. J Proteome Res, 7:5270–5276. 2008.
HanS. Force field parameters for S-nitrosocysteine and molecular dynamics simulations of S-nitrosated thioredoxin. Biochem Biophys Res Commun, 377:612–616. 2008.
93.
HansenJM, WatsonWH, JonesDP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci, 82:308–317. 2004.
94.
HansenRE, WintherJR. An introduction to methods for analyzing thiols and disulfides: reactions, reagents, and practical considerations. Anal Biochem, 394:147–158. 2009.
95.
HaoG, DerakhshanB, ShiL, CampagneF, GrossSS. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci U S A, 103:1012–1017. 2006.
96.
HashemySI, HolmgrenA. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem, 283:21890–21898. 2008.
97.
HaugstetterJ, BlicherT, EllgaardL. Identification and characterization of a novel thioredoxin-related transmembrane protein of the endoplasmic reticulum. J Biol Chem, 280:8371–8380. 2005.
98.
HayashiS, Hajiro-NakanishiK, MakinoY, EguchiH, YodoiJ, TanakaH. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res, 25:4035–4040. 1997.
99.
HeldJM, DanielsonSR, BehringJB, AtsrikuC, BrittonDJ, PuckettRL, SchillingB, CampisiJ, BenzCC, GibsonBW. Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Mol Cell Proteomics, 9:1400–1410. 2010.
100.
HessDT, MatsumotoA, KimSO, MarshallHE, StamlerJS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol, 6:150–166. 2005.
HirotaK, MatsuiM, IwataS, NishiyamaA, MoriK, YodoiJ. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A, 94:3633–3638. 1997.
104.
HirotaK, MurataM, SachiY, NakamuraH, TakeuchiJ, MoriK, YodoiJ. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem, 274:27891–27897. 1999.
105.
HoffmanMD, WalshGM, RogalskiJC, KastJ. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics, 8:887–903. 2009.
106.
HolmgrenA. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Methods Enzymol, 107:295–300. 1984.
107.
HolmgrenA. Thioredoxin. Annu Rev Biochem, 54:237–271. 1985.
108.
HolmgrenA. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem, 254:9627–9632. 1979.
109.
HolmgrenA. Thioredoxin and glutaredoxin systems. J Biol Chem, 264:13963–13966. 1989.
110.
HolmgrenA, LuJ. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun, 396:120–124. 2010.
HurdTR, PrimeTA, HarbourME, LilleyKS, MurphyMP. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: implications for mitochondrial redox signaling. J Biol Chem, 282:22040–22051. 2007.
113.
HwangCY, RyuYS, ChungMS, KimKD, ParkSS, ChaeSK, ChaeHZ, KwonKS. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene, 23:8868–8875. 2004.
114.
IbizaS, Perez-RodriguezA, OrtegaA, Martinez-RuizA, BarreiroO, Garcia-DominguezCA, VictorVM, EspluguesJV, RojasJM, Sanchez-MadridF, SerradorJM. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci U S A, 105:10507–10512. 2008.
115.
InomataY, TaniharaH, TanitoM, OkuyamaH, HoshinoY, KinumiT, KawajiT, KondoN, YodoiJ, NakamuraH. Suppression of choroidal neovascularization by thioredoxin-1 via interaction with complement factor H. Invest Ophthalmol Vis Sci, 49:5118–5125. 2008.
116.
IschiropoulosH. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun, 305:776–783. 2003.
117.
Jacquier-SarlinMR, PollaBS. Dual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxin. Biochem J, 318,Pt 1:187–193. 1996.
118.
JaffreySR, SnyderSH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE, 2001:pl1. 2001.
119.
JeongW, YoonHW, LeeSR, RheeSG. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function. J Biol Chem, 279:3142–3150. 2004.
120.
JiY, AkerboomTP, SiesH, ThomasJA. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys, 362:67–78. 1999.
121.
KahlosK, ZhangJ, BlockER, PatelJM. Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem, 254:47–54. 2003.
122.
KallisGB, HolmgrenA. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem, 255:10261–10265. 1980.
123.
KangSW, ChaeHZ, SeoMS, KimK, BainesIC, RheeSG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem, 273:6297–6302. 1998.
124.
KeszlerA, ZhangY, HoggN. Reaction between nitric oxide, glutathione, and oxygen in the presence and absence of protein: how are S-nitrosothiols formed?Free Radic Biol Med, 48:55–64. 2010.
125.
KimHY, KimJR. Thioredoxin as a reducing agent for mammalian methionine sulfoxide reductases B lacking resolving cysteine. Biochem Biophys Res Commun, 371:490–494. 2008.
126.
KimJR, YoonHW, KwonKS, LeeSR, RheeSG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem, 283:214–221. 2000.
127.
KimYM, TalanianRV, BilliarTR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem, 272:31138–31148. 1997.
128.
KirkpatrickL, DragovichT, RamanathanR, SharlowE, ChowS, WilliamsD, HimlerR, BakerA, EgorinM. Results from Phase I study of PX-12, a thioredoxin inhibitor in patients with advanced solid malignancies. J Clin Oncol, 22:3089. 2004.
KrauseG, LundstromJ, BareaJL, Pueyo de la CuestaC, HolmgrenA. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J Biol Chem, 266:9494–9500. 1991.
131.
KurookaH, KatoK, MinoguchiS, TakahashiY, IkedaJ, HabuS, OsawaN, BuchbergAM, MoriwakiK, ShisaH, HonjoT. Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics, 39:331–339. 1997.
132.
KusterGM, PimentelDR, AdachiT, IdoY, BrennerDA, CohenRA, LiaoR, SiwikDA, ColucciWS. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation, 111:1192–1198. 2005.
133.
KwonM, YoonCS, JeongW, RheeSG, WaismanDM. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J Biol Chem, 280:23584–23592. 2005.
134.
LancasterJRJr, GastonB. NO and nitrosothiols: spatial confinement and free diffusion. Am J Physiol Lung Cell Mol Physiol, 287:L465–L466. 2004.
LaneP, HaoG, GrossSS. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE, 2001:re1. 2001.
137.
LeeSR, KwonKS, KimSR, RheeSG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem, 273:15366–15372. 1998.
138.
LeeSR, YangKS, KwonJ, LeeC, JeongW, RheeSG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem, 277:20336–20342. 2002.
139.
LeeW, ChoiKS, RiddellJ, IpC, GhoshD, ParkJH, ParkYM. Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem, 282:22011–22022. 2007.
140.
LefievreL, ChenY, ConnerSJ, ScottJL, PublicoverSJ, FordWC, BarrattCL. Human spermatozoa contain multiple targets for protein S-nitrosylation: an alternative mechanism of the modulation of sperm function by nitric oxide?Proteomics, 7:3066–3084. 2007.
141.
LeichertLI, GehrkeF, GudisevaHV, BlackwellT, IlbertM, WalkerAK, StrahlerJR, AndrewsPC, JakobU. Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci U S A, 105:8197–8202. 2008.
142.
LewinA, CrowA, OubrieA, Le BrunNE. Molecular basis for specificity of the extracytoplasmic thioredoxin ResA. J Biol Chem, 281:35467–35477. 2006.
143.
LiF, SonveauxP, RabbaniZN, LiuS, YanB, HuangQ, VujaskovicZ, DewhirstMW, LiCY. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell, 26:63–74. 2007.
144.
LiJ, BilliarTR, TalanianRV, KimYM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun, 240:419–424. 1997.
145.
LiY, LiuW, XingG, TianC, ZhuY, HeF. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB. Cell Signal, 17:985–996. 2005.
146.
LilligCH, HolmgrenA. Thioredoxin and related molecules—from biology to health and disease. Antioxid Redox Signal, 9:25–47. 2007.
147.
LimKH, AncrileBB, KashatusDF, CounterCM. Tumour maintenance is mediated by eNOS. Nature, 452:646–649. 2008.
148.
LimaB, LamGK, XieL, DiesenDL, VillamizarN, NienaberJ, MessinaE, BowlesD, KontosCD, HareJM, StamlerJS, RockmanHA. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A, 106:6297–6302. 2009.
149.
LiptonSA, ChoiYB, TakahashiH, ZhangD, LiW, GodzikA, BankstonLA. Cysteine regulation of protein function—as exemplified by NMDA-receptor modulation. Trends Neurosci, 25:474–480. 2002.
LiuX, MillerMJ, JoshiMS, ThomasDD, LancasterJRJr. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A, 95:2175–2179. 1998.
152.
LiuY, MinW. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res, 90:1259–1266. 2002.
153.
Lopez-SanchezLM, CorralesFJ, Lopez-PedreraC, ArandaE, Rodriguez-ArizaA. Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells. Anticancer Res, 30:415–421. 2010.
LowFM, HamptonMB, PeskinAV, WinterbournCC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood, 109:2611–2617. 2007.
156.
Lundstrom-LjungJ, BirnbachU, RuppK, SolingHD, HolmgrenA. Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: comparison with protein disulfide isomerase. FEBS Lett, 357:305–308. 1995.
157.
MaiorinoM, UrsiniF, BoselloV, ToppoS, TosattoSC, MauriP, BeckerK, RoveriA, BulatoC, BenazziL, De PalmaA, FloheL. The thioredoxin specificity of Drosophila GPx: a paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases. J Mol Biol, 365:1033–1046. 2007.
158.
MakinoY, YoshikawaN, OkamotoK, HirotaK, YodoiJ, MakinoI, TanakaH. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem, 274:3182–3188. 1999.
159.
ManabeS, GuZ, LiptonSA. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci, 46:4747–4753. 2005.
160.
MancusoC, CaponeC, RanieriSC, FuscoS, CalabreseV, EboliML, PreziosiP, GaleottiT, PaniG. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res, 86:2235–2249. 2008.
161.
MancusoC, NavarraP, PreziosiP. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. J Neurochem, 113:563–575. 2010.
162.
MannickJB. Regulation of apoptosis by protein S-nitrosylation. Amino Acids, 32:523–526. 2007.
MarinoSM, GladyshevVN. Redox biology: computational approaches to the investigation of functional cysteine residues. Antioxid Redox Signal, 15:135–146. 2011.
166.
MarinoSM, GladyshevVN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol, 404:902–916. 2010.
167.
MarinoSM, GladyshevVN. Structural analysis of cysteine S-nitrosylation: a modified acid-based motif and the emerging role of trans-nitrosylation. J Mol Biol, 395:844–859. 2010.
168.
MarshallHE, StamlerJS. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J Biol Chem, 277:34223–34228. 2002.
169.
MartinJL. Thioredoxin—a fold for all reasons. Structure, 3:245–250. 1995.
170.
Martinez-RuizA, VillanuevaL, Gonzalez de OrdunaC, Lopez-FerrerD, HiguerasMA, TarinC, Rodriguez-CrespoI, VazquezJ, LamasS. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A, 102:8525–8530. 2005.
171.
MatsuoY, AkiyamaN, NakamuraH, YodoiJ, NodaM, Kizaka-KondohS. Identification of a novel thioredoxin-related transmembrane protein. J Biol Chem, 276:10032–10038. 2001.
172.
MatthewsJR, WakasugiN, VirelizierJL, YodoiJ, HayRT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res, 20:3821–3830. 1992.
173.
MatthiasLJ, YamPT, JiangXM, VandegraaffN, LiP, PoumbouriosP, DonoghueN, HoggPJ. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol, 3:727–732. 2002.
174.
McCarthySM, BovePF, MatthewsDE, AkaikeT, van der VlietA. Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. Biochemistry, 47:5832–5840. 2008.
175.
McDonaghB, OguetaS, LasarteG, PadillaCA, BarcenaJA. Shotgun redox proteomics identifies specifically modified cysteines in key metabolic enzymes under oxidative stress in Saccharomyces cerevisiae. J Proteomics, 72:677–689. 2009.
176.
McKinseyTA, ZhangCL, LuJ, OlsonEN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature, 408:106–111. 2000.
MelikianN, SeddonMD, CasadeiB, ChowienczykPJ, ShahAM. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med, 19:256–262. 2009.
179.
MeuilletEJ, MahadevanD, BerggrenM, CoonA, PowisG. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys, 429:123–133. 2004.
180.
MicheletL, ZaffagniniM, MarchandC, CollinV, DecottigniesP, TsanP, LancelinJM, TrostP, Miginiac-MaslowM, NoctorG, LemaireSD. Glutathionylation of chloroplast thioredoxin f is a redox signaling mechanism in plants. Proc Natl Acad Sci U S A, 102:16478–16483. 2005.
181.
MieyalJJ, GalloglyMM, QanungoS, SabensEA, SheltonMD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal, 10:1941–1988. 2008.
182.
MinettiM, MallozziC, Di StasiAM, PietraforteD. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys, 352:165–174. 1998.
183.
MitchellDA, ErwinPA, MichelT, MarlettaMA. S-nitrosation and regulation of inducible nitric oxide synthase. Biochemistry, 44:4636–4647. 2005.
184.
MitchellDA, MarlettaMA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol, 1:154–158. 2005.
185.
MitchellDA, MortonSU, FernhoffNB, MarlettaMA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc Natl Acad Sci U S A, 104:11609–11614. 2007.
186.
MohrS, HallakH, de BoitteA, LapetinaEG, BruneB. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem, 274:9427–9430. 1999.
187.
MotohashiK, KondohA, StumppMT, HisaboriT. Comprehensive survey of proteins targeted by chloroplast thioredoxin. Proc Natl Acad Sci U S A, 98:11224–11229. 2001.
188.
MusianiF, CiurliS, DikiyA. The interaction of selenoprotein W with 14-3-3 proteins: a computational approach. J Proteome Res, 10:968–976. 2011.
189.
NadeauPJ, CharetteSJ, ToledanoMB, LandryJ. Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H2O2-induced c-Jun NH2-terminal kinase activation and apoptosis. Mol Biol Cell, 18:3903–3913. 2007.
190.
NagaharaN, YoshiiT, AbeY, MatsumuraT. Thioredoxin-dependent enzymatic activation of mercaptopyruvate sulfurtransferase. An intersubunit disulfide bond serves as a redox switch for activation. J Biol Chem, 282:1561–1569. 2007.
191.
NakamuraH, NakamuraK, YodoiJ. Redox regulation of cellular activation. Annu Rev Immunol, 15:351–369. 1997.
192.
NakamuraT, LiptonSA. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal, 10:87–101. 2008.
NedospasovA, RafikovR, BedaN, NudlerE. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci U S A, 97:13543–13548. 2000.
195.
NedospasovAA. Is N2O3 the main nitrosating intermediate in aerated nitric oxide (NO) solutions in vivo? If so, where, when, and which one?J Biochem Mol Toxicol, 16:109–120. 2002.
196.
NikitovicD, HolmgrenA. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem, 271:19180–19185. 1996.
197.
NishiyamaA, MatsuiM, IwataS, HirotaK, MasutaniH, NakamuraH, TakagiY, SonoH, GonY, YodoiJ. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem, 274:21645–21650. 1999.
198.
NordstrandK, slundF, HolmgrenA, OttingG, BerndtKD. NMR structure of Escherichia coli glutaredoxin 3-glutathione mixed disulfide complex: implications for the enzymatic mechanism. J Mol Biol, 286:541–552. 1999.
199.
NottA, WatsonPM, RobinsonJD, CrepaldiL, RiccioA. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature, 455:411–415. 2008.
200.
Okado-MatsumotoA, MatsumotoA, FujiiJ, TaniguchiN. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem, 127:493–501. 2000.
201.
OliveiraL, BoutonC, DrapierJC. Thioredoxin activation of iron regulatory proteins. Redox regulation of RNA binding after exposure to nitric oxide. J Biol Chem, 274:516–521. 1999.
202.
OngSE, BlagoevB, KratchmarovaI, KristensenDB, SteenH, PandeyA, MannM. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics, 1:376–386. 2002.
PacherP, BeckmanJS, LiaudetL. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 87:315–424. 2007.
205.
PackerM, LeeWH, KesslerPD, GottliebSS, MedinaN, YushakM. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med, 317:799–804. 1987.
PanS, BerkBC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res, 100:213–219. 2007.
208.
ParkHS, YuJW, ChoJH, KimMS, HuhSH, RyooK, ChoiEJ. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem, 279:7584–7590. 2004.
209.
PatelJM, ZhangJ, BlockER. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol, 15:410–419. 1996.
210.
PatwariP, HigginsLJ, ChutkowWA, YoshiokaJ, LeeRT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem, 281:21884–21891. 2006.
211.
PawloskiJR, HessDT, StamlerJS. Export by red blood cells of nitric oxide bioactivity. Nature, 409:622–626. 2001.
212.
PengJ, EliasJE, ThoreenCC, LickliderLJ, GygiSP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res, 2:43–50. 2003.
213.
Perez-JimenezR, LiJ, KosuriP, Sanchez-RomeroI, WiitaAP, Rodriguez-LarreaD, ChuecaA, HolmgrenA, Miranda-VizueteA, BeckerK, ChoSH, BeckwithJ, GelhayeE, JacquotJP, GaucherEA, Sanchez-RuizJM, BerneBJ, FernandezJM. Diversity of chemical mechanisms in thioredoxin catalysis revealed by single-molecule force spectroscopy. Nat Struct Mol Biol, 16:890–896. 2009.
214.
Perez-MatoI, CastroC, RuizFA, CorralesFJ, MatoJM. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J Biol Chem, 274:17075–17079. 1999.
215.
PimentelDR, AdachiT, IdoY, HeibeckT, JiangB, LeeY, MelendezJA, CohenRA, ColucciWS. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol, 41:613–622. 2006.
216.
PowisG, MustacichD, CoonA. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med, 29:312–322. 2000.
217.
QinJ, CloreGM, KennedyWM, HuthJR, GronenbornAM. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure, 3:289–297. 1995.
218.
RaviK, BrennanLA, LevicS, RossPA, BlackSM. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci U S A, 101:2619–2624. 2004.
219.
ReiterE, LefkowitzRJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab, 17:159–165. 2006.
220.
RidnourLA, ThomasDD, MancardiD, EspeyMG, MirandaKM, PaolocciN, FeelischM, FukutoJ, WinkDA. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem, 385:1–10. 2004.
221.
RoosG, FoloppeN, Van LaerK, WynsL, NilssonL, GeerlingsP, MessensJ. How thioredoxin dissociates its mixed disulfide. PLoS Comput Biol, 5:e1000461. 2009.
RossiR, LusiniL, GianneriniF, GiustariniD, LungarellaG, Di SimplicioP. A method to study kinetics of transnitrosation with nitrosoglutathione: reactions with hemoglobin and other thiols. Anal Biochem, 254:215–220. 1997.
224.
RozellB, HanssonHA, LuthmanM, HolmgrenA. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol, 38:79–86. 1985.
225.
SabensEA, MieyalJJ. Glutaredoxin and thioredoxin enzyme systems: catalytic mechanisms and physiological functions. Glutathione and Sulfur Amino Acids in Human Health and Disease. MasellaR, MassaG. Hoboken, NJ: John Wiley & Sons, Inc., 2009; 121–156.
226.
SaitohM, NishitohH, FujiiM, TakedaK, TobiumeK, SawadaY, KawabataM, MiyazonoK, IchijoH. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J, 17:2596–2606. 1998.
227.
SanthanamL, LimHK, MirielV, BrownT, PatelM, BalansonS, RyooS, AndersonM, IraniK, KhandayF, Di CostanzoL, NyhanD, HareJM, ChristiansonDW, RiversR, ShoukasA, BerkowitzDE. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res, 101:692–702. 2007.
228.
SauerH, WartenbergM, HeschelerJ. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem, 11:173–186. 2001.
229.
SavilleB. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst, 83:670–675. 1958.
230.
SayedN, BaskaranP, MaX, van den AkkerF, BeuveA. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci U S A, 104:12312–12317. 2007.
231.
SayedN, KimDD, FioramontiX, IwahashiT, DuranWN, BeuveA. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res, 103:606–614. 2008.
232.
SchroederP, PoppR, WiegandB, AltschmiedJ, HaendelerJ. Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells—important role for nuclear thioredoxin-1. Arterioscler Thromb Vasc Biol, 27:2325–2331. 2007.
SchwarzO, SchurmannP, StrotmannH. Kinetics and thioredoxin specificity of thiol modulation of the chloroplast H+-ATPase. J Biol Chem, 272:16924–16927. 1997.
SenguptaR, BilliarTR, StoyanovskyDA. Studies toward the analysis of S-nitrosoproteins. Org Biomol Chem, 7:232–234. 2009.
238.
SenguptaR, RyterSW, ZuckerbraunBS, TzengE, BilliarTR, StoyanovskyDA. Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. Biochemistry, 46:8472–8483. 2007.
239.
SeoMS, KangSW, KimK, BainesIC, LeeTH, RheeSG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem, 275:20346–20354. 2000.
StamlerJS, MeissnerG. Physiology of nitric oxide in skeletal muscle. Physiol Rev, 81:209–237. 2001.
247.
StoyanovskyDA, TyurinaYY, TyurinVA, AnandD, MandaviaDN, GiusD, IvanovaJ, PittB, BilliarTR, KaganVE. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc, 127:15815–15823. 2005.
248.
StubauerG, GiuffreA, SartiP. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem, 274:28128–28133. 1999.
249.
SumbayevVV. S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1. Arch Biochem Biophys, 415:133–136. 2003.
250.
SunJ. Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning. Sheng Li Xue Bao, 59:544–552. 2007.
251.
SunJ, MorganM, ShenRF, SteenbergenC, MurphyE. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res, 101:1155–1163. 2007.
252.
SunJ, XinC, EuJP, StamlerJS, MeissnerG. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A, 98:11158–11162. 2001.
253.
TamuraT, StadtmanTC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci U S A, 93:1006–1011. 1996.
TaoL, GaoE, BryanNS, QuY, LiuHR, HuA, ChristopherTA, LopezBL, YodoiJ, KochWJ, FeelischM, MaXL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc Natl Acad Sci U S A, 101:11471–11476. 2004.
256.
TaoL, JiaoX, GaoE, LauWB, YuanY, LopezB, ChristopherT, RamachandraRaoSP, WilliamsW, SouthanG, SharmaK, KochW, MaXL. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation, 114:1395–1402. 2006.
257.
TelloD, TarinC, AhicartP, Breton-RomeroR, LamasS, Martinez-RuizA. A “fluorescence switch” technique increases the sensitivity of proteomic detection and identification of S-nitrosylated proteins. Proteomics, 9:5359–5370. 2009.
258.
UedaS, NakamuraH, MasutaniH, SasadaT, YoneharaS, TakabayashiA, YamaokaY, YodoiJ. Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J Immunol, 161:6689–6695. 1998.
259.
VaninAF, MalenkovaIV, SerezhenkovVA. Iron catalyzes both decomposition and synthesis of S-nitrosothiols: optical and electron paramagnetic resonance studies. Nitric Oxide, 1:191–203. 1997.
260.
VenemaRC, VenemaVJ, JuH, HarrisMB, SneadC, JillingT, DimitropoulouC, MaragoudakisME, CatravasJD. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol, 285:H669–H678. 2003.
261.
VerdoucqL, VignolsF, JacquotJP, ChartierY, MeyerY. In vivo characterization of a thioredoxin h target protein defines a new peroxiredoxin family. J Biol Chem, 274:19714–19722. 1999.
262.
Vieira Dos SantosC, LaugierE, TarragoL, MassotV, Issakidis-BourguetE, RouhierN, ReyP. Specificity of thioredoxins and glutaredoxins as electron donors to two distinct classes of Arabidopsis plastidial methionine sulfoxide reductases B. FEBS Lett, 581:4371–4376. 2007.
263.
von KnethenA, CallsenD, BruneB. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell, 10:361–372. 1999.
264.
WagnerE, LucheS, PennaL, ChevalletM, Van DorsselaerA, Leize-WagnerE, RabilloudT. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem J, 366:777–785. 2002.
265.
WangD, MasutaniH, OkaS, TanakaT, Yamaguchi-IwaiY, NakamuraH, YodoiJ. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J Biol Chem, 281:7384–7391. 2006.
266.
WangG, MoniriNH, OzawaK, StamlerJS, DaakaY. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci U S A, 103:1295–1300. 2006.
267.
WangY, LiuT, WuC, LiH. A strategy for direct identification of protein S-nitrosylation sites by quadrupole time-of-flight mass spectrometry. J Am Soc Mass Spectrom, 19:1353–1360. 2008.
268.
WatsonWH, PohlJ, MontfortWR, StuchlikO, ReedMS, PowisG, JonesDP. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem, 278:33408–33415. 2003.
269.
WeichselA, BraileyJL, MontfortWR. Buried S-nitrosocysteine revealed in crystal structures of human thioredoxin. Biochemistry, 46:1219–1227. 2007.
270.
WhalenEJ, FosterMW, MatsumotoA, OzawaK, ViolinJD, QueLG, NelsonCD, BenharM, KeysJR, RockmanHA, KochWJ, DaakaY, LefkowitzRJ, StamlerJS. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell, 129:511–522. 2007.
271.
WiitaAP, Perez-JimenezR, WaltherKA, GraterF, BerneBJ, HolmgrenA, Sanchez-RuizJM, FernandezJM. Probing the chemistry of thioredoxin catalysis with force. Nature, 450:124–127. 2007.
272.
WongJH, BalmerY, CaiN, TanakaCK, VenselWH, HurkmanWJ, BuchananBB. Unraveling thioredoxin-linked metabolic processes of cereal starchy endosperm using proteomics. FEBS Lett, 547:151–156. 2003.
YamamotoM, YangGP, HongC, LiuJ, HolleE, YuXZ, WagnerT, VatnerSF, SadoshimaJ. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest, 112:1395–1406. 2003.
276.
YamazakiD, MotohashiK, KasamaT, HaraY, HisaboriT. Target proteins of the cytosolic thioredoxins in Arabidopsis thaliana. Plant Cell Physiol, 45:18–27. 2004.
277.
YangKS, KangSW, WooHA, HwangSC, ChaeHZ, KimK, RheeSG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem, 277:38029–38036. 2002.
278.
YanoH, WongJH, LeeYM, ChoMJ, BuchananBB. A strategy for the identification of proteins targeted by thioredoxin. Proc Natl Acad Sci U S A, 98:4794–4799. 2001.
279.
YoshiokaJ, SchreiterER, LeeRT. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal, 8:2143–2151. 2006.
280.
ZhangH, TaoL, JiaoX, GaoE, LopezBL, ChristopherTA, KochW, MaXL. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic Biol Med, 43:39–47. 2007.
281.
ZhangR, Al-LamkiR, BaiL, StrebJW, MianoJM, BradleyJ, MinW. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res, 94:1483–1491. 2004.
282.
ZhangX, HuangB, ZhouX, ChenC. Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method. Protein Cell, 1:675–687. 2010.
283.
ZhouJ, DamdimopoulosAE, SpyrouG, BruneB. Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha. J Biol Chem, 282:7482–7490. 2007.
284.
ZhouY, KokKH, ChunAC, WongCM, WuHW, LinMC, FungPC, KungH, JinDY. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun, 268:921–927. 2000.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
